Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
Mankind Pharma
About
Mankind Pharma is a pharmaceutical company that develops, commercializes, and delivers medicines for urgent medical needs.
- New Delhi,Delhi,India
- 10001 - max
- https://www.mankindpharma.com
Details
- Last Funding Type
- Private Equity（PE）
- Last Funding Money Raised
- $24M
- Industries
- Health Care,Pharmaceutical
- Founded date
- Jan 1, 1995
- Number Of Employee
- 10001 - max
- Operating Status
- Active
- Legal Name
- MANKIND PHARMA LTD.
Mankind Pharma aspires to aid the community in a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. Mankind Pharma came into existence in 1986, and in 1991, the company was formed into a legal corporation. However, it actively started working as a fully-integrated pharmaceutical company in 1995. Today, Mankind has an employee base of over 14,000 and is racing towards $1 Billion.The company takes great pride in the success of its products ranging from Pharma, OTC, and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Adiction, Gas-O-Fast, Kaloree 1 and many others.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 28, 2015 | Secondary Market | $215M | 1 |
|
— | Detail |
| Apr 30, 2007 | Private Equity（PE） | $24M | 2 |
Chrys Capital
|
— | Detail |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jun 23, 2022
BatX Energies
|
Seed | ₹130M | Energy | — |
|
Mar 21, 2022
Leverage Edu
|
Series B | $22M | Artificial Intelligence | — |
|
Jan 19, 2022
Dogsee Chew
|
Series A | ₹500M | Food and Beverage | Yes |
|
Aug 11, 2021
Miko
|
Series B | ₹2.13B | Artificial Intelligence | Yes |
|
Jun 9, 2021
Eight Sleep
|
Angel | — | Consumer Electronics | — |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
Yes | Secondary Market |
|
Chrys Capital
|
Yes | Private Equity（PE） |
HarbourVest Partners
|
— | Private Equity（PE） |
Employee Profiles
Acquisition
Mankind Pharma has acquired 2 organizations. Their most recent acquisition was Panacea Biotec Pharma - Formulations business on Feb 1, 2022. They acquired Panacea Biotec Pharma - Formulations business for ₹19.08B.
|
Date
Company Name
|
Industry | Acquisition Type | Price | |
|---|---|---|---|---|
|
Feb 1, 2022
Panacea Biotec Pharma - Formulations business
|
Biopharma | acquisition | ₹ 19.08B | Detail |
|
Nov 28, 2022
Upakarma Ayurveda Private Limited
|
Health Care | acquisition | — | Detail |
